A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients

被引:26
作者
Alqahtani, Fahad [1 ]
Koulouridis, Ioannis [1 ,2 ]
Susantitaphong, Paweena [1 ,2 ,3 ]
Dahal, Khagendra [1 ]
Jaber, Bertrand L. [1 ,2 ]
机构
[1] St Elizabeths Med Ctr, Kidney & Dialysis Res Lab, Dept Med, Div Nephrol, Boston, MA 02135 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Chulalongkorn Univ, Extracorporeal Multiorgan Support Dialysis Ctr, King Chulalongkorn Mem Hosp, Div Nephrol,Dept Med,Fac Med, Bangkok 10330, Thailand
关键词
Meta-analysis; Loop diuretics; Infusion; Continuous; Intermittent; Urine output; HIGH-DOSE FUROSEMIDE; ACUTE-RENAL-FAILURE; BOLUS INJECTION; HEART-FAILURE; DOUBLE-BLIND; MANAGEMENT; FRUSEMIDE; EFFICACY; DIURESIS;
D O I
10.1016/j.jcrc.2013.03.015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Several studies have examined the potential benefits of continuous vs intermittent (bolus) intravenous loop diuretic administration in hospitalized patients with conflicting results. We conducted a meta-analysis to compare the efficacy of these 2 strategies in hospitalized adults and children with extracellular fluid volume expansion. Methods: We searched MEDLINE (through October 2012) and prior meta-analyses for randomized controlled trials comparing the efficacy of continuous vs intermittent infusion of loop diuretics. Random-effects model meta-analyses were performed to examine several outcomes, including net change in urine output and body weight. Results: We identified 7 crossover and 11 parallel-arm randomized controlled trials (936 patients) of adults and children. In the 15 studies of adults, continuous loop diuretic infusion resulted in a nonsignificant net increase in daily urine output of 334 mL (95% confidence interval [CI], -74 to 742; P = .11) relative to the bolus infusion. In the 8 studies that used a loading dose, continuous loop diuretic infusion resulted in a significant net increase in daily urine output of 294 mL (95% CI, 31-557; P = .03) relative to the intermittent infusion. There was also a significant net decrease in body weight of 0.78 kg (95% CI, -1.54 to -0.03; P = .04) in the continuous relative to the intermittent loop diuretic infusion. In the 3 studies of children, there was no demonstrable effect on daily urine output or body weight. Conclusion: Continuous infusion of loop diuretics preceded by a loading dose results in greater diuresis in hospitalized adults with extracellular fluid volume expansion compared with intermittent dosing regimens. Further studies are required to examine whether these benefits translate into improved clinical outcomes. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 36 条
[1]   Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure [J].
Aaser, E ;
Gullestad, L ;
Tollofsrud, S ;
Lundberg, J ;
Hall, C ;
Djoseland, O ;
Kjekshus, J ;
Forfang, K .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (04) :361-367
[2]   Continuous Versus Bolus Dosing of Furosemide for Patients Hospitalized for Heart Failure [J].
Allen, Larry A. ;
Turer, Asian T. ;
DeWald, Tracy ;
Stough, Wendy Gattis ;
Cotter, Gadi ;
O'Connor, Christopher M. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12) :1794-1797
[3]   Continuous infusion versus intermittent bolus furosemide in ADHF: An updated meta-analysis of randomized control trials [J].
Amer, Muhammad ;
Adomaityte, Jurga ;
Qayyum, Rehan .
JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (03) :270-275
[4]  
Begatin J, 1993, PHARMACA, V31, P279
[5]  
Brater D C, 1991, Drugs, V41 Suppl 3, P14
[6]   BUMETANIDE AND FUROSEMIDE IN HEART-FAILURE [J].
BRATER, DC ;
DAY, B ;
BURDETTE, A ;
ANDERSON, S .
KIDNEY INTERNATIONAL, 1984, 26 (02) :183-189
[7]  
Brater DC, 1987, CONTEMP ISS NEPHROL, P115
[8]  
BROWN CB, 1981, CLIN NEPHROL, V15, P90
[9]  
Brunton LL, 2010, GOODMAN GILMANS PHAR
[10]   High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial [J].
Cantarovich, F ;
Rangoonwala, B ;
Lorenz, H ;
Verho, M ;
Esnault, VLM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (03) :402-409